NAD+ repletion rescues female fertility during reproductive aging
Bertoldo, Michael J.; Listijono, Dave R.; Ho, Wing-Hong Jonathan; Riepsamen, Angelique H.; Goss, Dale M.; Richani, Dulama; Jin, Xing L.; Mahbub, Saabah; Campbell, Jared M.; Habibalahi, Abbas; Loh, Wei-Guo Nicholas; Youngson, Nell A.; Maniam, Jayanthi; Wong, Ashley S.A.; Selesniemi, Kaisa; Bustamante, Sonia; Li, Catherine; Zhao, Yiqing; Marinova, Maria B.; Kim, Lynn-Jee; Lau, Laurin; Wu, Rachael M.; Mikolaizak, Stefanie A.; Araki, Toshiyuki; Le Couteur, David G.; Turner, Nigel; Morris, Margaret J.; Walters, Kirsty A.; Goldys, Ewa; O'Neill, Christopher; Gilchrist, Robert B.; Sinclair, David A.; Homer, Hayden A.; Wu, Lindsay E.
Date:
2020
Publication:
Cell Reports;30 (6), pp. 1670-1681
Publication type:
Article
Abstract:
Reproductive aging in female mammals is an irreversible process associated with declining oocyte quality, which is the rate-limiting factor to fertility. Here, we show that this loss of oocyte quality with age accompanies declining levels of the prominent metabolic cofactor nicotinamide adenine dinucleotide (NAD+). Treatment with the NAD+ metabolic precursor nicotinamide mononucleotide (NMN) rejuvenates oocyte quality in aged animals, leading to restoration in fertility, and this can be recapitulated by transgenic overexpression of the NAD+-dependent deacylase SIRT2, though deletion of this enzyme does not impair oocyte quality. These benefits of NMN extend to the developing embryo, where supplementation reverses the adverse effect of maternal age on developmental milestones. These findings suggest that late-life restoration of NAD+ levels represents an opportunity to rescue female reproductive function in mammals.
Description:
peer-reviewed
Show full item record
